Multiple-level stakeholders’ perspectives on barriers and facilitators of HPV vaccination delivery in Western and Central Kenya: a qualitative study
Authors:
Open Access
- 8 October 2026
- journal article
- Published by BMJ in BMJ Public Health
- Vol. 4 (4) , e005069
Abstract
Background Human papillomavirus (HPV) vaccination is critical for achieving cervical cancer elimination. In Kenya, HPV vaccination coverage progressed slowly since the launch of the national vaccination programme in 2019. We sought to assess the barriers and facilitators of HPV vaccination delivery from the perspective of multilevel stakeholders involved in HPV vaccination in Kenya.Methods Using a qualitative approach, we interviewed multilevel stakeholders involved in vaccination delivery across multiple levels of the health system in three counties and nationally between February and July 2023. Participants were purposively sampled based on their role in HPV vaccination delivery. We used in-depth interview guides informed by the consolidated framework for implementation research. Interviews were audio-recorded, transcribed and translated into English when necessary. Data were analysed using deductive and inductive thematic approaches.Results Overall, we interviewed 52 participants, including 22 (42%) community leaders, 19 (37%) healthcare providers and 11 (21%) decision-makers. 34 participants (65%) were females. Participants had been in their role for 9 years on average (IQR: 3–12). Stakeholders reported that strong global, regional and local evidence supported national implementation of HPV vaccination. Adaptations to the intervention, including school-based and community-based vaccination, complemented facility-based approaches and increased coverage. Additionally, the availability of vaccination resources, together with adequate stakeholder engagement, training and motivation, was critical for HPV vaccination delivery. Conversely, training gaps and limited dissemination of evidence to key stakeholders hindered vaccination delivery. Furthermore, logistical constraints, poor coordination and communication among stakeholders and the lack of parental consent challenged school-based delivery. Facility-based vaccination was impeded by inadequate infrastructure and staffing, while community hesitancy hindered vaccination uptake due to inadequate knowledge, insufficient early involvement of key community stakeholders, myths and misinformation.Conclusions Context-specific approaches that include cross-sectoral collaboration efforts among HPV vaccination stakeholders and targeted sensitisation within communities could improve HPV vaccination delivery and uptake in Kenya and comparable settings.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-010402)
This publication has 51 references indexed in Scilit:
- Global HPV vaccination programs and coverage rates: a systematic revieweClinicalMedicine, 2025
- Knowledge of human papillomavirus vaccine as a determinant of uptake among guardians of adolescent girls: A single hospital experience in nairobi, kenyaGlobal Pediatrics, 2025
- Evidence for an HPV one-dose scheduleVaccine, 2024
- Human papilloma virus vaccination in the resource-limited settings of sub-Saharan Africa: Challenges and recommendationsVaccine: X, 2024
- Overcoming Vaccine Hesitancy Using Community-Based EffortsPediatric Clinics of North America, 2023
- Integration of other services with human papillomavirus vaccination; lessons from earlier in the life course highlight the need for new policy and implementation evidenceVaccine, 2022
- Incidence, Treatment and Outcomes of Cervical Cancer in Low- and Middle-income CountriesClinical Oncology, 2021
- Status of HPV vaccine introduction and barriers to country uptakeVaccine, 2018
- Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016Papillomavirus Research, 2017
- Saturation in qualitative research: exploring its conceptualization and operationalizationQuality & Quantity, 2017